• Pcas

  • Marc De Rocquefeuil

Marc De Rocquefeuil

Director at Pcas

Joined Seqens in 2009

Member of the Management board, he was previously CFO of the group from 2009 to 2014 ;

Prior to that, he served as CFO of one of the French subsidiaries of Danaher from 1992 to 2007 and as CFO at Lamberet from 2007 to 2009

Graduated in Finance from the Angers Business School


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Pcas

Pcas SA, formerly Produits Chimiques Auxiliaires Et De Synthese SA, is a France-based company engaged in the development and manufacture of complex molecules for life sciences and specialty chemicals markets. It operates through nine production sites and two main business units, Pharma Synthesis and Fine & Specialty Chemicals. Pharma Synthesis unit specializes in active pharmaceutical ingredients (API), intermediates and building blocks, and early phase services, among others. Fine & Specialty Chemicals unit focuses on custom manufacturing and proprietary products, such as fragrance, flavor ingredients, imaging and microelectronics chemicals. The Company operates several subsidiaries, including Saint-Jean Photochimie, Societe Bearnaise de Synthese, Expansia, PCAS BioMatrix Inc, based in Canada, and PCAS Finland Oy, based in Finland, among others.


Industries

Headquarters

Longjumeau, France

Employees

1,001-5,000

Links